MedTrace Logo

Visceral Abdominal Fat, Non Alcoholic Fatty Liver Diseases and Asymptomatic Coronary Atherosclerosis

NCT01282892 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2011-01-25

No results posted yet for this study

Summary

Visceral fat or peri-omental fat is increasingly associated with metabolic syndrome, a condition carrying a high risk of coronary artery disease. The independent role of Visceral Fat in cardiovascular risk remains unclear.

Patients with excess of visceral fat and NAFLD patients will have higher prevalence of coronary atherosclerosis plaques independently by metabolic syndrome diagnosis. Suggesting that the presence of visceral fat and/or fatty liver will be considered an important condition to optimize the cardiovascular risk stratification

Conditions

Interventions

PROCEDURE

excess of visceral fat

excess of visceral fat

PROCEDURE

patients with NAFLD

patients with NAFLD

Sponsors & Collaborators

  • Ziv Hospital

    lead OTHER_GOV

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2009-11-30
Completion
2010-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01282892 on ClinicalTrials.gov